SAMTOR and cancer: Although SAMTOR and mTORC1 have been implicated in methionine sensing, our data suggests that this pathway does not underlie methionine dependence in cancer, as mTORC1 signaling remains active even when methionine is depleted and cells are supplemented with homocysteine, conditions under which cancer cells rapidly arrest.